Scientists Just Found a Major Flaw in a Key COVID Drug Study

Scientists just found a major flaw in a key COVID drug study

A promising path to fighting COVID and other coronaviruses may have been based on a serious mistake. Scientists had zeroed in on a part of the virus called the NiRAN domain, believed to be a powerful target for new antiviral drugs. But when a Rockefeller team revisited a highly cited 2022 study, they found the evidence didn’t hold up. Key molecules shown in the original virus model were actually missing. Their discovery could help prevent wasted…

Rockefeller Team Finds Flawed Data in Recent Study Relevant to Coronavirus Antiviral Development

New research demonstrates that a previously published structure and mechanism for RNA capping at work in coronaviruses is incorrect, with potentially sweeping implications for the quest to develop drugs targeting these pathogens.